122 related articles for article (PubMed ID: 37708549)
21. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer.
Lin H; ChangChien CC; Huang EY; Tseng CW; Eng HL; Huang CC
Acta Obstet Gynecol Scand; 2000 Feb; 79(2):140-4. PubMed ID: 10696963
[TBL] [Abstract][Full Text] [Related]
22. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
23. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
24. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
[TBL] [Abstract][Full Text] [Related]
25. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
[TBL] [Abstract][Full Text] [Related]
26. Serum CYFRA21-1 and SCC-Ag levels in women during pregnancy and their diagnostic value for cervical cancer.
Zhang Q; Wang Z; Tang H; Zhang B; Yue C; Gao J; Ying C
Cancer Treat Res Commun; 2024; 38():100786. PubMed ID: 38198984
[TBL] [Abstract][Full Text] [Related]
27. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
Ogino I; Nakayama H; Kitamura T; Okamoto N; Inoue T
Int J Gynecol Cancer; 2005; 15(4):630-8. PubMed ID: 16014117
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
Chen P; Jiao L; Ren F; Wang DB
BMC Cancer; 2020 May; 20(1):423. PubMed ID: 32410650
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer.
Chen W; Xiu S; Xie X; Guo H; Xu Y; Bai P; Xia X
Radiat Oncol; 2022 Jan; 17(1):6. PubMed ID: 35012582
[TBL] [Abstract][Full Text] [Related]
30. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
[TBL] [Abstract][Full Text] [Related]
31. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
Charakorn C; Thadanipon K; Chaijindaratana S; Rattanasiri S; Numthavaj P; Thakkinstian A
Gynecol Oncol; 2018 Jul; 150(1):190-200. PubMed ID: 29606483
[TBL] [Abstract][Full Text] [Related]
32. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY
Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221
[TBL] [Abstract][Full Text] [Related]
34. Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
Li W; Xiong L; Zhu Q; Lu H; Zhong M; Liang M; Jiang W; Wang Y; Cheng W
BMC Cancer; 2021 May; 21(1):484. PubMed ID: 33933005
[TBL] [Abstract][Full Text] [Related]
35. Time-Dependent Squamous Cell Carcinoma Antigen in Prediction of Relapse and Death of Patients With Cervical Cancer.
Chang C; Chen J; Huang CH; Lee WY; Hsu LC; Chiang AJ
J Low Genit Tract Dis; 2020 Jan; 24(1):38-42. PubMed ID: 31860573
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
[TBL] [Abstract][Full Text] [Related]
37. The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma.
Wang Y; Cui T; Du L; Xu X; Tian B; Sun T; Han C; Zhao X; Jing J
J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27435426
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
Salvatici M; Achilarre MT; Sandri MT; Boveri S; Vanna Z; Landoni F
Gynecol Oncol; 2016 Jul; 142(1):115-119. PubMed ID: 27117922
[TBL] [Abstract][Full Text] [Related]
39. The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
Ye S; Sun X; Kang B; Wu F; Zheng Z; Xiang L; Lesénéchal M; Heskia F; Liang J; Yang H
BMC Cancer; 2020 Feb; 20(1):138. PubMed ID: 32085736
[TBL] [Abstract][Full Text] [Related]
40. Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients.
Porika M; Vemunoori AK; Tippani R; Mohammad A; Bollam SR; Abbagani S
Asian Pac J Cancer Prev; 2010; 11(6):1745-7. PubMed ID: 21338226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]